The stratified win statistics (win ratio, win odds, and net benefit)
Pharmaceutical Statistics · 2023-07 · 22 (4) · 748-756
DOI: 10.1002/pst.2293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Statistics, online erschienen am 20.02.2023. Verfasst von Gaohong Dong und 6 weiteren Autor:innen. Beteiligte Einrichtung: BeiGene, Ridgefield Park, New Jersey, USA. Hauptthemen laut MEDLINE: Probability. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
The win odds and the net benefit are related directly to each other and indirectly, through ties, to the win ratio. These three win statistics test the same null hypothesis of equal win probabilities between two groups. They provide similar p ‐values and powers, because the Z‐values of their statistical tests are approximately equal. Thus, they can complement one another to show the strength of a treatment effect. In this article, we show that the estimated variances of the win statistics are also directly related regardless of ties or indirectly related through ties. Since its introduction in 2018, the stratified win ratio has been applied in designs and analyses of clinical trials, including Phase III and Phase IV studies. This article generalizes the stratified method to the win odds and the net benefit. As a result, the relations of the three win statistics and the approximate equivalence of their statistical tests also hold for the stratified win statistics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- BeiGene, Ridgefield Park, New Jersey, USA.
- Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, Massachusetts, USA.
- Pfizer Inc., Groton, Connecticut, USA.
- Department of Biostatistics and Bioinformatics, Emory University, Atlanta, Georgia, USA.
- Liverpool School of Tropical Medicine, Liverpool, UK.
- Department of Statistics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Gaohong Dong, David C Hoaglin, Bo Huang, Margaret Gamalo-Siebers
Zitieren
APA
Dong, G., Hoaglin, D. C., Huang, B., Cui, Y., Wang, D., Cheng, Y., & Gamalo-Siebers, M. (2023). The stratified win statistics (win ratio, win odds, and net benefit). Pharmaceutical Statistics, 22(4), 748-756. https://doi.org/10.1002/pst.2293
Vancouver
Dong G, Hoaglin DC, Huang B, Cui Y, Wang D, Cheng Y, et al. The stratified win statistics (win ratio, win odds, and net benefit). Pharmaceutical Statistics. 2023;22(4):748-756. doi:10.1002/pst.2293
BibTeX
@article{Dong2023,
author = {Dong, Gaohong and Hoaglin, David C and Huang, Bo and Cui, Ying and Wang, Duolao and Cheng, Yu and Gamalo-Siebers, Margaret},
title = {The stratified win statistics (win ratio, win odds, and net benefit)},
journal = {Pharmaceutical Statistics},
year = {2023},
volume = {22},
number = {4},
pages = {748--756},
doi = {10.1002/pst.2293}
}
EUVIMED